ResultsIQ

ResultsIQ › Latest results › Tata Chemicals Limited

Tata Chemicals Limited Q2 FY27 earnings call summary

NSE: TATACHEM · BSE: 500770

Earnings call of 7 Nov 2026, summarised by AI from the filing.

Tata Chemicals posted a Q2 FY27 consolidated loss after tax of ₹50 cr as U.K. gas costs and soda ash oversupply hit results.

Key takeaways

  1. Consolidated loss Q2 FY27 loss after tax ₹50 cr against a profit, on lower overseas realisation, U.K. energy costs and Kenya suspension.
  2. Capex guidance Around ₹1,000 cr for the current year including growth projects; next year around the same level.
  3. Soda ash oversupply Persistent oversupply and weak China demand keep global soda ash prices and margins under pressure.

Original filing on BSE

Tata Chemicals Limited Q2 FY27 results

As filed: Revenue ₹4,177 cr (+8% year on year), EBITDA ₹381 cr (−29% year on year), PAT −₹50.0 cr (−132% year on year), EBITDA margin 9.1% (−473 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹4,255 cr (+14% year on year), EBITDA ₹555 cr (−14% year on year), PAT ₹60.0 cr (−81% year on year), EBITDA margin 13.0% (−441 bps). Score 44 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 441 bps year on year. Other income 44% of PBT. Tax rate 39%. Consolidated profit -81% but standalone +12%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −8.8% in 30 days (Nifty 500: +1.8%).
  • Q4 FY26: Revenue ₹3,438 cr (−2% year on year), EBITDA ₹274 cr (−16% year on year), PAT −₹2,116 cr, EBITDA margin 8.0% (−135 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 135 bps year on year. Revenue fell 3% from last quarter. Share price after the results: −10.7% in 30 days (Nifty 500: −1.7%).
  • Q3 FY26: Revenue ₹3,550 cr (−1% year on year), EBITDA ₹345 cr (−21% year on year), PAT −₹69.0 cr (−265% year on year), EBITDA margin 9.7% (−237 bps). Score 20 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit before exceptional items growth was well below it. EBITDA margin fell 237 bps year on year. Revenue fell 8% from last quarter. Share price after the results: −2.6% in 30 days (Nifty 500: −1.9%).
  • Q2 FY26: Revenue ₹3,877 cr (−3% year on year), EBITDA ₹537 cr (−13% year on year), PAT ₹154 cr (−19% year on year), EBITDA margin 13.9% (−160 bps). Score 27 of 100, Below trend. Revenue, EBITDA and profit before exceptional items growth were below the company's own trend. EBITDA margin fell 160 bps year on year. Other income 76% of PBT. Tax rate 45%. Consolidated profit -42% but standalone +80%. Profit fell 23% from last quarter. Share price after the results: −10.7% in 30 days (Nifty 500: +0.9%).
  • Q1 FY26: Revenue ₹3,719 cr (−2% year on year), EBITDA ₹649 cr (+13% year on year), PAT ₹316 cr (+66% year on year), EBITDA margin 17.5% (+230 bps). Score 54 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were above it. EBITDA margin rose 230 bps year on year. Other income 30% of PBT. Tax rate 14%. Share price after the results: −0.4% in 28 days (Nifty 500: −0.1%).
  • Q4 FY25: Revenue ₹3,509 cr (+1% year on year), EBITDA ₹327 cr (−26% year on year), PAT −₹49.0 cr (−139% year on year), EBITDA margin 9.3% (−343 bps). Score 20 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 343 bps year on year. Profit fell 279% from last quarter. Share price after the results: +13.1% in 30 days (Nifty 500: +5.0%).
  • Q3 FY25: Revenue ₹3,590 cr (−4% year on year), EBITDA ₹434 cr (−20% year on year), PAT −₹21.0 cr (−83% year on year), EBITDA margin 12.1% (−244 bps). Score 32 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 244 bps year on year. Revenue fell 10% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Tata Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.